Skip to main content

Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.

Publication ,  Journal Article
Thomas, DW; Mannon, RB; Mannon, PJ; Latour, A; Oliver, JA; Hoffman, M; Smithies, O; Koller, BH; Coffman, TM
Published in: J Clin Invest
December 1, 1998

Thromboxane A2 (TXA2) is a labile metabolite of arachidonic acid that has potent biological effects. Its actions are mediated by G protein-coupled thromboxane-prostanoid (TP) receptors. TP receptors have been implicated in the pathogenesis of cardiovascular diseases. To investigate the physiological functions of TP receptors, we generated TP receptor-deficient mice by gene targeting. Tp-/- animals reproduce and survive in expected numbers, and their major organ systems are normal. Thromboxane agonist binding cannot be detected in tissues from Tp-/- mice. Bleeding times are prolonged in Tp-/- mice and their platelets do not aggregate after exposure to TXA2 agonists. Aggregation responses after collagen stimulation are also delayed, although ADP-stimulated aggregation is normal. Infusion of the TP receptor agonist U-46619 causes transient increases in blood pressure followed by cardiovascular collapse in wild-type mice, but U-46619 caused no hemodynamic effect in Tp-/- mice. Tp-/- mice are also resistant to arachidonic acid-induced shock, although arachidonic acid signifi-cantly reduced blood pressure in Tp-/- mice. In summary, Tp-/- mice have a mild bleeding disorder and altered vascular responses to TXA2 and arachidonic acid. Our studies suggest that most of the recognized functions of TXA2 are mediated by the single known Tp gene locus.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Invest

DOI

ISSN

0021-9738

Publication Date

December 1, 1998

Volume

102

Issue

11

Start / End Page

1994 / 2001

Location

United States

Related Subject Headings

  • Thromboxane A2
  • Shock
  • Receptors, Thromboxane
  • Platelet Aggregation Inhibitors
  • Platelet Aggregation
  • Mice, Knockout
  • Mice, Inbred DBA
  • Mice, Inbred C57BL
  • Mice
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thomas, D. W., Mannon, R. B., Mannon, P. J., Latour, A., Oliver, J. A., Hoffman, M., … Coffman, T. M. (1998). Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest, 102(11), 1994–2001. https://doi.org/10.1172/JCI5116
Thomas, D. W., R. B. Mannon, P. J. Mannon, A. Latour, J. A. Oliver, M. Hoffman, O. Smithies, B. H. Koller, and T. M. Coffman. “Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.J Clin Invest 102, no. 11 (December 1, 1998): 1994–2001. https://doi.org/10.1172/JCI5116.
Thomas DW, Mannon RB, Mannon PJ, Latour A, Oliver JA, Hoffman M, et al. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest. 1998 Dec 1;102(11):1994–2001.
Thomas, D. W., et al. “Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.J Clin Invest, vol. 102, no. 11, Dec. 1998, pp. 1994–2001. Pubmed, doi:10.1172/JCI5116.
Thomas DW, Mannon RB, Mannon PJ, Latour A, Oliver JA, Hoffman M, Smithies O, Koller BH, Coffman TM. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest. 1998 Dec 1;102(11):1994–2001.

Published In

J Clin Invest

DOI

ISSN

0021-9738

Publication Date

December 1, 1998

Volume

102

Issue

11

Start / End Page

1994 / 2001

Location

United States

Related Subject Headings

  • Thromboxane A2
  • Shock
  • Receptors, Thromboxane
  • Platelet Aggregation Inhibitors
  • Platelet Aggregation
  • Mice, Knockout
  • Mice, Inbred DBA
  • Mice, Inbred C57BL
  • Mice
  • Male